FDA Inspection 1323654 — Daniel B. Landi, M.D.
The FDA completed an inspection of Daniel B. Landi, M.D. on Jun 12, 2026 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 12, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Durham, NC (United States)
Additional Details
Clinical Investigator (CI)